Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 375

1.

DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.

Díaz-García CV, Agudo-López A, Pérez C, López-Martín JA, Rodríguez-Peralto JL, de Castro J, Cortijo A, Martínez-Villanueva M, Iglesias L, García-Carbonero R, Fresno Vara JA, Gámez-Pozo A, Palacios J, Cortés-Funes H, Paz-Ares L, Agulló-Ortuño MT.

Carcinogenesis. 2013 May;34(5):1031-8. doi: 10.1093/carcin/bgt022. Epub 2013 Jan 24.

PMID:
23349018
2.

A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.

Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C, Wan J, Zhou F, Shao K, Sun Y, Wu J, Zhang X, Qiu B, Li N, Shi S, Feng X, Zhao S, Wang Z, Zhao X, Chen Z, Mitchelson K, Cheng J, Guo Y, He J.

Clin Cancer Res. 2011 Nov 1;17(21):6802-11. doi: 10.1158/1078-0432.CCR-11-0419. Epub 2011 Sep 2.

3.

High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.

Czubak K, Lewandowska MA, Klonowska K, Roszkowski K, Kowalewski J, Figlerowicz M, Kozlowski P.

Oncotarget. 2015 Sep 15;6(27):23399-416.

4.

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.

Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH, Zhang YK.

Med Oncol. 2012 Jun;29(2):618-26. doi: 10.1007/s12032-011-9923-y. Epub 2011 Apr 24.

PMID:
21516486
5.

A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.

Campayo M, Navarro A, Viñolas N, Tejero R, Muñoz C, Diaz T, Marrades R, Cabanas ML, Gimferrer JM, Gascon P, Ramirez J, Monzo M.

PLoS One. 2011;6(7):e22509. doi: 10.1371/journal.pone.0022509. Epub 2011 Jul 25.

6.

The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes.

Eide HA, Halvorsen AR, Bjaanæs MM, Piri H, Holm R, Solberg S, Jørgensen L, Brustugun OT, Kiserud CE, Helland Å.

BMC Cancer. 2016 Feb 8;16:71. doi: 10.1186/s12885-016-2104-9.

7.

Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.

Hamamoto J, Soejima K, Yoda S, Naoki K, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Yasuda H, Hayashi Y, Sakamoto M, Takebayashi T, Betsuyaku T.

Mol Med Rep. 2013 Aug;8(2):456-62. doi: 10.3892/mmr.2013.1517. Epub 2013 Jun 11.

PMID:
23759980
8.

Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.

PMID:
23756108
9.

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.

J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134. Epub 2009 Mar 9.

PMID:
19273703
10.

Dicer, Drosha, and outcomes in patients with ovarian cancer.

Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, Sood AK.

N Engl J Med. 2008 Dec 18;359(25):2641-50. doi: 10.1056/NEJMoa0803785. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

11.

Knock-down of core proteins regulating microRNA biogenesis has no effect on sensitivity of lung cancer cells to ionizing radiation.

Surova O, Akbar NS, Zhivotovsky B.

PLoS One. 2012;7(3):e33134. doi: 10.1371/journal.pone.0033134. Epub 2012 Mar 30.

12.

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.

Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH.

Clin Cancer Res. 2010 Jan 15;16(2):610-9. doi: 10.1158/1078-0432.CCR-09-2638. Epub 2010 Jan 12.

13.

miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.

Zhang YK, Zhu WY, He JY, Chen DD, Huang YY, Le HB, Liu XG.

J Cancer Res Clin Oncol. 2012 Oct;138(10):1641-50. Epub 2012 May 22.

PMID:
22618509
14.

MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.

Davidson MR, Larsen JE, Yang IA, Hayward NK, Clarke BE, Duhig EE, Passmore LH, Bowman RV, Fong KM.

PLoS One. 2010 Sep 3;5(9):e12560. doi: 10.1371/journal.pone.0012560.

15.

Prognostic value of microRNA expression in operable non-small cell lung cancer patients.

Skrzypski M, Czapiewski P, Goryca K, Jassem E, Wyrwicz L, Pawłowski R, Rzyman W, Biernat W, Jassem J.

Br J Cancer. 2014 Feb 18;110(4):991-1000. doi: 10.1038/bjc.2013.786. Epub 2014 Jan 21.

16.

Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.

Vincenzi B, Zoccoli A, Schiavon G, Iuliani M, Pantano F, Dell'aquila E, Ratta R, Muda AO, Perrone G, Brunelli C, Correale P, Riva E, Russo A, Loupakis F, Falcone A, Santini D, Tonini G.

Eur J Cancer. 2013 Apr;49(6):1501-8. doi: 10.1016/j.ejca.2012.11.014. Epub 2012 Dec 22.

PMID:
23266047
17.

Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.

Capodanno A, Boldrini L, Proietti A, Alì G, Pelliccioni S, Niccoli C, D'Incecco A, Cappuzzo F, Chella A, Lucchi M, Mussi A, Fontanini G.

Int J Oncol. 2013 Sep;43(3):765-74. doi: 10.3892/ijo.2013.2003. Epub 2013 Jul 2.

PMID:
23820752
18.

Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.

Fassina A, Cappellesso R, Fassan M.

Chest. 2011 Nov;140(5):1305-1311. doi: 10.1378/chest.11-0708. Epub 2011 May 26.

PMID:
21622546
19.

Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.

Duncavage E, Goodgame B, Sezhiyan A, Govindan R, Pfeifer J.

J Thorac Oncol. 2010 Nov;5(11):1755-63. doi: 10.1097/JTO.0b013e3181f3909d.

20.

Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.

Tafsiri E, Darbouy M, Shadmehr MB, Zagryazhskaya A, Alizadeh J, Karimipoor M.

Tumour Biol. 2015 Mar;36(3):1603-12. doi: 10.1007/s13277-014-2755-6. Epub 2014 Nov 11.

PMID:
25384507

Supplemental Content

Support Center